REG - MDGH - GMTN B.V. - Disposal

OMV AGAnnouncement

12/03/2020 09:25

RNS Number : 9016F
  
MDGH - GMTN B.V.
  
12 March 2020
  
 

THIS ANNOUNCEMENT RELATES TO THE DISCLOSURE OF INFORMATION THAT QUALIFIED OR MAY HAVE QUALIFIED AS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE MARKET ABUSE REGULATION (EU) 596/2014.
 
Mamoura Diversified Global Holding PJSC - Sale of majority shareholding in Borealis AG to OMV AG
 
Mubadala Petroleum and Petrochemicals Holding Company LLC, a subsidiary of Mamoura Diversified Global Holding PJSC (MDGH), has today entered into an agreement to sell an indirect interest in 39 per cent. of the share capital of Borealis AG  to OMV Refining & Marketing GmbH, a subsidiary of OMV AG, for a total consideration of USD4,680,000,000. The transaction is expected to close in Q4 2020 and is subject to regulatory approvals. Following completion, Mubadala Petroleum and Petrochemicals Holding Company LLC will retain a 25 per cent. interest in Borealis AG.
 
For further information, please contact:
 
Mamoura Diversified Global Holding PJSC
P.O. Box 45005, Abu Dhabi, United Arab Emirates
 



Telephone:


+971 2 413 0000




Fax:


+971 2 413 0001




Email:


ir@mubadala.ae (for investor relations queries) media@mubadala.ae (for media queries) 



 
This announcement is released by MDGH - GMTN B.V. and contains information that qualified or may have qualified as inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 (MAR), encompassing information relating to the Global Medium Term Note Programme established by MDGH - GMTN B.V. and unconditionally and irrevocably guaranteed by Mamoura Diversified Global Holding PJSC. For the purposes of MAR and Article 2 of Commission Implementing Regulation (EU) 2016/1055, this announcement is made by Abdulla Mubarak Abdulla Al Darmaki  as director of MDGH - GMTN B.V. 
 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
  END
 
 
DISFIFLTVEIFLII